Literature DB >> 28382425

Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes.

Katja Schumacher1, Nikolaos Dagres1, Gerhard Hindricks1, Daniela Husser1, Andreas Bollmann1, Jelena Kornej2.   

Abstract

The PR interval may be considered as a simple and easily obtainable predictor for adverse events, including atrial fibrillation (AF), pacemaker implantation, and mortality. Interestingly, both high and low extremes of the PR duration are associated with AF risk. However, the results regarding PR prolongation as a risk factor for AF are inconsistent. Some studies have analyzed the impact of P duration (as a part of the PR interval) and demonstrated that the P-duration contributes to the length of PR interval and adverse outcomes. The PR prolongation could be considered as a marker for cardiovascular degenerative aging caused by myocardial fibrosis and vascular inflammation. Furthermore, due to PR prolongation chronically raised intra-atrial pressure and consequential neuro-hormonal activation predispose systemic vascular endothelial dysfunction and explain the associations with adverse vascular events. In this review, we discuss the association between biomarkers with PR interval in AF.

Entities:  

Keywords:  AF incidence; Atrial fibrillation; Biomarkers; P wave morphology; PR prolongation

Mesh:

Year:  2017        PMID: 28382425     DOI: 10.1007/s00392-017-1109-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  48 in total

1.  Mechanisms of sex and age differences in ventricular repolarization in humans.

Authors:  Jose Vicente; Lars Johannesen; Loriano Galeotti; David G Strauss
Journal:  Am Heart J       Date:  2014-07-24       Impact factor: 4.749

Review 2.  Fibrosis and cardiac arrhythmias.

Authors:  Sanne de Jong; Toon A B van Veen; Harold V M van Rijen; Jacques M T de Bakker
Journal:  J Cardiovasc Pharmacol       Date:  2011-06       Impact factor: 3.105

3.  Prolongation of PR interval is associated with endothelial dysfunction and activation of vascular repair in high-risk cardiovascular patients.

Authors:  Yap-Hang Chan; Chung-Wah Siu; Kai-Hang Yiu; Yuen-Fung Yiu; Kui-Kai Lau; Tai-Hing Lam; Chu-Pak Lau; Hung-Fat Tse
Journal:  J Interv Card Electrophysiol       Date:  2013-02-07       Impact factor: 1.900

4.  Genome-wide association study of electrocardiographic conduction measures in an isolated founder population: Kosrae.

Authors:  J Gustav Smith; Jennifer K Lowe; Sirisha Kovvali; Julian B Maller; Jacqueline Salit; Mark J Daly; Markus Stoffel; David M Altshuler; Jeffrey M Friedman; Jan L Breslow; Christopher Newton-Cheh
Journal:  Heart Rhythm       Date:  2009-02-15       Impact factor: 6.343

5.  Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

Authors:  Renate B Schnabel; Martin G Larson; Jennifer F Yamamoto; Sekar Kathiresan; Jian Rong; Daniel Levy; John F Keaney; Thomas J Wang; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Am J Cardiol       Date:  2009-05-04       Impact factor: 2.778

6.  N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Patrick T Ellinor; Susan R Heckbert; Robert H Christenson; Christopher DeFilippi; John S Gottdiener; Richard A Kronmal
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

7.  Impact of metabolic syndrome on left atrial electroanatomical remodeling and outcomes after radiofrequency ablation of nonvalvular atrial fibrillation.

Authors:  Borislav Dinov; Jedrzej Kosiuk; Simon Kircher; Andreas Bollmann; Willem-Jan Acou; Arash Arya; Gerhard Hindricks; Sascha Rolf
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-05-15

8.  Relationships of High-sensitive C-reactive Protein and P-wave Dispersion in Lone Atrial Fibrillation.

Authors:  Li-Hui Zheng; Yan Yao; Ling-Min Wu; Kui-Jun Zhang; Shu Zhang
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

9.  Response of high-sensitive C-reactive protein to catheter ablation of atrial fibrillation and its relation with rhythm outcome.

Authors:  Jelena Kornej; Claudia Reinhardt; Jedrzej Kosiuk; Arash Arya; Gerhard Hindricks; Volker Adams; Daniela Husser; Andreas Bollmann
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

10.  In silico Prediction of Sex-Based Differences in Human Susceptibility to Cardiac Ventricular Tachyarrhythmias.

Authors:  Pei-Chi Yang; Colleen E Clancy
Journal:  Front Physiol       Date:  2012-09-14       Impact factor: 4.566

View more
  17 in total

Review 1.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Falco Kosich; Katja Schumacher; Tatjana Potpara; Gregory Y Lip; Gerhard Hindricks; Jelena Kornej
Journal:  Clin Cardiol       Date:  2019-01-14       Impact factor: 2.882

3.  Flow-mediated dilation, nitroglycerin-mediated dilation and their ratio predict successful renal denervation in mild resistant hypertension.

Authors:  Martin Steinmetz; Dominik Nelles; Jutta Weisser-Thomas; Christian Schaefer; Georg Nickenig; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2018-04-11       Impact factor: 5.460

4.  Evidence for cardiotoxicity associated with sertraline in rats.

Authors:  Sinem Ilgin; Volkan Kilic; Merve Baysal; Gozde Aydogan-Kilic; Seyda Ucarcan; Begum Dermenci; Ozlem Atli
Journal:  Toxicol Res (Camb)       Date:  2018-04-06       Impact factor: 3.524

5.  The incidence, indications and predictors of acute pacemaker implantation after ablation of persistent atrial fibrillation.

Authors:  Verena Semmler; Felix von Krogh; Bernhard Haller; Tilko Reents; Felix Bourier; Marta Telishevska; Marc Kottmaier; Marielouise Kornmayer; Stephanie Brooks; Katharina Koch-Büttner; Carsten Lennerz; Amir Brkic; Christian Grebmer; Patrick Blazek; Severin Weigand; Gabriele Hessling; Christof Kolb; Isabel Deisenhofer
Journal:  Clin Res Cardiol       Date:  2018-11-20       Impact factor: 5.460

6.  Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure.

Authors:  Theodora Nikolaidou; Pierpaolo Pellicori; Jufen Zhang; Syed Kazmi; Kevin M Goode; John G Cleland; Andrew L Clark
Journal:  Clin Res Cardiol       Date:  2017-09-15       Impact factor: 5.460

7.  Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers.

Authors:  Maurizio Acampa; Pietro E Lazzerini; Giuseppe Martini
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

8.  Physiologic heart rate dependency of the PQ interval and its sex differences.

Authors:  Ondřej Toman; Katerina Hnatkova; Peter Smetana; Katharina M Huster; Martina Šišáková; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

9.  Electrocardiogram findings at the initiation of hemodialysis and types of subsequent cardiovascular events.

Authors:  Satoshi Yamaguchi; Takayuki Hamano; Tatsufumi Oka; Yohei Doi; Sachio Kajimoto; Seiichi Yasuda; Karin Shimada; Ayumi Matsumoto; Yusuke Sakaguchi; Kazunori Inoue; Isao Matsui; Akira Suzuki; Yoshitaka Isaka
Journal:  Hypertens Res       Date:  2021-01-04       Impact factor: 3.872

10.  Are the atrial natriuretic peptides a missing link predicting low-voltage areas in atrial fibrillation? Introducing the novel biomarker-based atrial fibrillation substrate prediction (ANP) score.

Authors:  Timm Seewöster; Petra Büttner; Samira Zeynalova; Gerhard Hindricks; Jelena Kornej
Journal:  Clin Cardiol       Date:  2020-05-27       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.